PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort
出版年份 2021 全文链接
标题
PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort
作者
关键词
-
出版物
Journal of Translational Medicine
Volume 19, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-06-24
DOI
10.1186/s12967-021-02937-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A review of cancer immunotherapy toxicity
- (2020) Lucy Boyce Kennedy et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Performance status and end‐of‐life care among adults with non–small cell lung cancer receiving immune checkpoint inhibitors
- (2020) Laura A. Petrillo et al. CANCER
- Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study
- (2020) Alessio Cortellini et al. OncoImmunology
- Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/ Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-related adverse events
- (2020) Alessio Cortellini et al. EUROPEAN JOURNAL OF CANCER
- Immune Checkpoint Inhibitors for Patients Aged ≥ 75 Years with Advanced Cancer in First- and Second-Line Settings: A Meta-Analysis
- (2020) Thierry Landre et al. DRUGS & AGING
- Factors associated with the initiation of chemotherapy within 90 days of death in metastatic colorectal cancer patients: a population-based study
- (2020) Atul Batra et al. SUPPORTIVE CARE IN CANCER
- Clinical Outcomes of Patients with Metastatic Cancer Receiving Immune Checkpoint Inhibitors in the Inpatient Setting
- (2020) Sienna M. Durbin et al. ONCOLOGIST
- Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index
- (2020) Sebastiano Buti et al. EUROPEAN JOURNAL OF CANCER
- A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable
- (2019) Alessio Cortellini et al. Journal for ImmunoTherapy of Cancer
- Clinical Outcomes of Patients with Advanced Cancer and Pre‐Existing Autoimmune Diseases Treated with Anti‐Programmed Death‐1 Immunotherapy: A Real‐World Transverse Study
- (2019) Alessio Cortellini et al. ONCOLOGIST
- Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients
- (2019) Alessio Cortellini et al. Clinical Lung Cancer
- Trends in Checkpoint Inhibitor Therapy for Advanced Urothelial Cell Carcinoma at the End of Life: Insights from Real‐World Practice
- (2019) Ravi B. Parikh et al. ONCOLOGIST
- Immune Checkpoint Inhibitor Use Near the End of Life Is Associated With Poor Performance Status, Lower Hospice Enrollment, and Dying in the Hospital
- (2019) Chad Glisch et al. American Journal of Hospice & Palliative Medicine
- Influence of age on the efficacy of immune checkpoint inhibitors in advanced cancers: a systematic review and meta-analysis
- (2019) Kiichiro Ninomiya et al. ACTA ONCOLOGICA
- Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: an insight from clinical practice
- (2019) Alessio Cortellini et al. Journal of Translational Medicine
- Palliative Chemotherapy Near the End of Life in Oncology Patients
- (2018) Zhe Zhang et al. American Journal of Hospice & Palliative Medicine
- Re-Evaluating Eligibility Criteria for Oncology Clinical Trials: Analysis of Investigational New Drug Applications in 2015
- (2017) Susan Jin et al. JOURNAL OF CLINICAL ONCOLOGY
- Chemotherapy Use in the Months Before Death and Estimated Costs of Care in the Last Week of Life
- (2016) Melissa M. Garrido et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- American Society of Clinical Oncology Identifies Five Key Opportunities to Improve Care and Reduce Costs: The Top Five List for Oncology
- (2012) Lowell E. Schnipper et al. JOURNAL OF CLINICAL ONCOLOGY
- Factors That Affect the Duration of the Interval Between the Completion of Palliative Chemotherapy and Death
- (2009) K. Hashimoto et al. ONCOLOGIST
- Aggressiveness of Cancer Care Near the End of Life: Is It a Quality-of-Care Issue?
- (2008) Craig C. Earle et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started